Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes

D. C. Kalter, M. Nakamura, J. A. Turpin, L. M. Baca, D. L. Hoover, C. Dieffenbach, P. Ralph, Howard Eliot Gendelman, M. S. Meltzer

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

Monocytes cultured 7 to 10 days in recombinant human macrophage CSF (MCSF) were >400-fold more susceptible to HIV infection than an equal number of cells cultured in medium alone. Levels of reverse transcriptase activity and p24 Ag in culture fluids of monocytes treated with MCSF 1 wk before and continuously after HIV infection were significantly greater than those of control cells cultured without MCSF. HIV-induced cytopathic effects in the MCSF-treated cultures also increased in both frequency and extent. At any given viral inoculum, the frequency of HIV-infected cells, the level of HIV mRNA/infected cell, and the level of proviral DNA/infected culture in MCSF-treated monocyte cultures were dramatically greater than those in control cultures. These differences were directly related to MCSF concentration to a maximum between 750 and 1000 U/ml MCSF, and were evident at all time points examined through 5 wk. None of the preceding effects was observed when MCSF was added at the time of or 1 wk after HIV infection. These data suggest that the predominant effect of MCSF for control of HIV infection is on the monocyte itself, not the virus. If these in vitro observations extend to the HIV-infected patient, then the variable levels of MCSF in tissue or blood may determine both the susceptibility of macrophages to virus infection and the extent of virus replication in infected cells.

Original languageEnglish (US)
Pages (from-to)298-306
Number of pages9
JournalJournal of Immunology
Volume146
Issue number1
StatePublished - Jan 1 1991

Fingerprint

Macrophage Colony-Stimulating Factor
Monocytes
Macrophages
HIV
HIV Infections
Cultured Cells
RNA-Directed DNA Polymerase
Virus Diseases
Virus Replication
Cell Count
Viruses

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Kalter, D. C., Nakamura, M., Turpin, J. A., Baca, L. M., Hoover, D. L., Dieffenbach, C., ... Meltzer, M. S. (1991). Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. Journal of Immunology, 146(1), 298-306.

Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. / Kalter, D. C.; Nakamura, M.; Turpin, J. A.; Baca, L. M.; Hoover, D. L.; Dieffenbach, C.; Ralph, P.; Gendelman, Howard Eliot; Meltzer, M. S.

In: Journal of Immunology, Vol. 146, No. 1, 01.01.1991, p. 298-306.

Research output: Contribution to journalArticle

Kalter, DC, Nakamura, M, Turpin, JA, Baca, LM, Hoover, DL, Dieffenbach, C, Ralph, P, Gendelman, HE & Meltzer, MS 1991, 'Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes', Journal of Immunology, vol. 146, no. 1, pp. 298-306.
Kalter DC, Nakamura M, Turpin JA, Baca LM, Hoover DL, Dieffenbach C et al. Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. Journal of Immunology. 1991 Jan 1;146(1):298-306.
Kalter, D. C. ; Nakamura, M. ; Turpin, J. A. ; Baca, L. M. ; Hoover, D. L. ; Dieffenbach, C. ; Ralph, P. ; Gendelman, Howard Eliot ; Meltzer, M. S. / Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes. In: Journal of Immunology. 1991 ; Vol. 146, No. 1. pp. 298-306.
@article{f16e88ef4a1945fdb5570ca15f3d8cf2,
title = "Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes",
abstract = "Monocytes cultured 7 to 10 days in recombinant human macrophage CSF (MCSF) were >400-fold more susceptible to HIV infection than an equal number of cells cultured in medium alone. Levels of reverse transcriptase activity and p24 Ag in culture fluids of monocytes treated with MCSF 1 wk before and continuously after HIV infection were significantly greater than those of control cells cultured without MCSF. HIV-induced cytopathic effects in the MCSF-treated cultures also increased in both frequency and extent. At any given viral inoculum, the frequency of HIV-infected cells, the level of HIV mRNA/infected cell, and the level of proviral DNA/infected culture in MCSF-treated monocyte cultures were dramatically greater than those in control cultures. These differences were directly related to MCSF concentration to a maximum between 750 and 1000 U/ml MCSF, and were evident at all time points examined through 5 wk. None of the preceding effects was observed when MCSF was added at the time of or 1 wk after HIV infection. These data suggest that the predominant effect of MCSF for control of HIV infection is on the monocyte itself, not the virus. If these in vitro observations extend to the HIV-infected patient, then the variable levels of MCSF in tissue or blood may determine both the susceptibility of macrophages to virus infection and the extent of virus replication in infected cells.",
author = "Kalter, {D. C.} and M. Nakamura and Turpin, {J. A.} and Baca, {L. M.} and Hoover, {D. L.} and C. Dieffenbach and P. Ralph and Gendelman, {Howard Eliot} and Meltzer, {M. S.}",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "146",
pages = "298--306",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes

AU - Kalter, D. C.

AU - Nakamura, M.

AU - Turpin, J. A.

AU - Baca, L. M.

AU - Hoover, D. L.

AU - Dieffenbach, C.

AU - Ralph, P.

AU - Gendelman, Howard Eliot

AU - Meltzer, M. S.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Monocytes cultured 7 to 10 days in recombinant human macrophage CSF (MCSF) were >400-fold more susceptible to HIV infection than an equal number of cells cultured in medium alone. Levels of reverse transcriptase activity and p24 Ag in culture fluids of monocytes treated with MCSF 1 wk before and continuously after HIV infection were significantly greater than those of control cells cultured without MCSF. HIV-induced cytopathic effects in the MCSF-treated cultures also increased in both frequency and extent. At any given viral inoculum, the frequency of HIV-infected cells, the level of HIV mRNA/infected cell, and the level of proviral DNA/infected culture in MCSF-treated monocyte cultures were dramatically greater than those in control cultures. These differences were directly related to MCSF concentration to a maximum between 750 and 1000 U/ml MCSF, and were evident at all time points examined through 5 wk. None of the preceding effects was observed when MCSF was added at the time of or 1 wk after HIV infection. These data suggest that the predominant effect of MCSF for control of HIV infection is on the monocyte itself, not the virus. If these in vitro observations extend to the HIV-infected patient, then the variable levels of MCSF in tissue or blood may determine both the susceptibility of macrophages to virus infection and the extent of virus replication in infected cells.

AB - Monocytes cultured 7 to 10 days in recombinant human macrophage CSF (MCSF) were >400-fold more susceptible to HIV infection than an equal number of cells cultured in medium alone. Levels of reverse transcriptase activity and p24 Ag in culture fluids of monocytes treated with MCSF 1 wk before and continuously after HIV infection were significantly greater than those of control cells cultured without MCSF. HIV-induced cytopathic effects in the MCSF-treated cultures also increased in both frequency and extent. At any given viral inoculum, the frequency of HIV-infected cells, the level of HIV mRNA/infected cell, and the level of proviral DNA/infected culture in MCSF-treated monocyte cultures were dramatically greater than those in control cultures. These differences were directly related to MCSF concentration to a maximum between 750 and 1000 U/ml MCSF, and were evident at all time points examined through 5 wk. None of the preceding effects was observed when MCSF was added at the time of or 1 wk after HIV infection. These data suggest that the predominant effect of MCSF for control of HIV infection is on the monocyte itself, not the virus. If these in vitro observations extend to the HIV-infected patient, then the variable levels of MCSF in tissue or blood may determine both the susceptibility of macrophages to virus infection and the extent of virus replication in infected cells.

UR - http://www.scopus.com/inward/record.url?scp=0026071123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026071123&partnerID=8YFLogxK

M3 - Article

VL - 146

SP - 298

EP - 306

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -